HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Wu Selected Research

3'-O-methylorobol

12/20193'-O-Methylorobol Inhibits the Voltage-Gated Sodium Channel Nav1.7 with Anti-Itch Efficacy in A Histamine-Dependent Itch Mouse Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Wu Research Topics

Disease

187Neoplasms (Cancer)
08/2022 - 03/2000
79Infections
07/2022 - 03/2005
46Breast Neoplasms (Breast Cancer)
03/2022 - 06/2011
29Inflammation (Inflammations)
07/2022 - 05/2006
27Neoplasm Metastasis (Metastasis)
03/2022 - 10/2011
25Hepatocellular Carcinoma (Hepatoma)
07/2022 - 02/2007
22Plague (Bubonic Plague)
07/2022 - 01/2016
20Virus Diseases (Viral Diseases)
05/2022 - 05/2008
19Hypoxia (Hypoxemia)
12/2021 - 06/2006
18Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 07/2011
17Stomach Neoplasms (Stomach Cancer)
01/2022 - 03/2010
17Carcinogenesis
01/2022 - 05/2008
16Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2015
16Fibrosis (Cirrhosis)
01/2022 - 11/2007
16Obesity
12/2021 - 04/2002
16Type 2 Diabetes Mellitus (MODY)
01/2021 - 10/2008
16Enteritis
01/2021 - 12/2010
14Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2002
13Melanoma (Melanoma, Malignant)
03/2022 - 01/2018
13Hypertension (High Blood Pressure)
03/2022 - 04/2011
13Insulin Resistance
01/2021 - 01/2012
12Lung Neoplasms (Lung Cancer)
01/2022 - 12/2012
12Neuralgia (Stump Neuralgia)
01/2021 - 06/2012
12Carcinoma (Carcinomatosis)
09/2017 - 09/2003
11Pain (Aches)
01/2022 - 02/2004
11Colonic Neoplasms (Colon Cancer)
04/2015 - 01/2008
10COVID-19
03/2022 - 05/2020
10Triple Negative Breast Neoplasms
11/2021 - 03/2016
9Adenocarcinoma of Lung
07/2021 - 04/2015
9HIV Infections (HIV Infection)
11/2014 - 08/2003
8Body Weight (Weight, Body)
07/2022 - 05/2005
8Bites and Stings (Sting)
03/2022 - 01/2018
8Atrial Fibrillation
01/2022 - 01/2014
8Seizures (Absence Seizure)
01/2021 - 01/2006
8Glioma (Gliomas)
12/2020 - 11/2002
8Hyperalgesia
12/2018 - 02/2004
7Rheumatoid Arthritis
03/2022 - 08/2009
7Disease Progression
01/2022 - 01/2012
7Cardiovascular Diseases (Cardiovascular Disease)
08/2019 - 12/2011
6Hypersensitivity (Allergy)
11/2021 - 07/2006
6Wounds and Injuries (Trauma)
06/2021 - 12/2012
6Lymphatic Metastasis
04/2021 - 06/2013
6Adenocarcinoma
04/2021 - 06/2010
6Osteoporosis
02/2021 - 11/2017
6Cognitive Dysfunction
11/2020 - 04/2009
6Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020 - 04/2006

Drug/Important Bio-Agent (IBA)

107Proteins (Proteins, Gene)FDA Link
07/2022 - 12/2003
63Biomarkers (Surrogate Marker)IBA
02/2022 - 04/2007
36MicroRNAs (MicroRNA)IBA
05/2022 - 03/2010
29Long Noncoding RNAIBA
07/2022 - 04/2015
23Messenger RNA (mRNA)IBA
07/2022 - 03/2005
23Pharmaceutical PreparationsIBA
05/2022 - 01/2005
23Glucose (Dextrose)FDA LinkGeneric
01/2022 - 10/2008
22Biological ProductsIBA
05/2022 - 05/2008
22Antiviral Agents (Antivirals)IBA
05/2022 - 12/2010
21RNA (Ribonucleic Acid)IBA
07/2022 - 01/2006
19VaccinesIBA
05/2022 - 06/2007
17DNA (Deoxyribonucleic Acid)IBA
07/2022 - 07/2004
17CytokinesIBA
01/2022 - 03/2010
17LipidsIBA
01/2021 - 06/2007
14Phosphotransferases (Kinase)IBA
04/2022 - 12/2013
13Peptides (Polypeptides)IBA
06/2022 - 10/2011
13Interleukin-6 (Interleukin 6)IBA
01/2022 - 03/2013
13Small Interfering RNA (siRNA)IBA
01/2022 - 03/2005
12InterferonsIBA
03/2022 - 06/2002
12EnzymesIBA
01/2022 - 01/2009
11Therapeutic UsesIBA
01/2021 - 01/2005
10CateninsIBA
06/2022 - 01/2006
10Estrogen ReceptorsIBA
03/2022 - 06/2016
10Insulin (Novolin)FDA Link
01/2018 - 04/2009
9Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 02/2012
9ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2013
9Triglycerides (Triacylglycerol)IBA
01/2021 - 07/2009
9Indicators and Reagents (Reagents)IBA
06/2020 - 06/2011
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2019 - 05/2004
8AntibodiesIBA
05/2022 - 12/2003
7Caspase 3 (Caspase-3)IBA
07/2022 - 06/2007
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2022 - 05/2005
7Transcription Factors (Transcription Factor)IBA
04/2022 - 12/2010
7NucleotidesIBA
01/2022 - 10/2008
7AntigensIBA
04/2021 - 04/2007
7human ERBB2 proteinIBA
02/2021 - 04/2017
7Immune Checkpoint InhibitorsIBA
01/2021 - 01/2019
6CollagenIBA
08/2022 - 01/2019
6Peptide Hydrolases (Proteases)FDA Link
01/2022 - 11/2017
6C-Reactive ProteinIBA
11/2021 - 05/2011
6Glycoproteins (Glycoprotein)IBA
06/2021 - 05/2011
6CalciumIBA
01/2021 - 12/2007
6AlbuminsIBA
01/2021 - 08/2016
6AdiponectinIBA
01/2020 - 01/2012
6Glutamate Carboxypeptidase II (N-Acetylaspartylglutamate Peptidase)IBA
10/2019 - 12/2012
6Antineoplastic Agents (Antineoplastics)IBA
04/2018 - 01/2009
6ParaffinIBA
01/2017 - 04/2006

Therapy/Procedure

79Therapeutics
06/2022 - 03/2000
41Drug Therapy (Chemotherapy)
01/2022 - 05/2004
11Radiotherapy
01/2022 - 11/2018
9Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2022 - 02/2012
9Immunotherapy
03/2021 - 09/2017
7Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2022 - 10/2017
6Lasers (Laser)
09/2018 - 06/2007